nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyltestosterone—CYP19A1—Paclitaxel—kidney cancer	0.172	0.257	CbGbCtD
Methyltestosterone—CYP3A4—Everolimus—kidney cancer	0.0942	0.14	CbGbCtD
Methyltestosterone—ALB—Erlotinib—kidney cancer	0.0761	0.113	CbGbCtD
Methyltestosterone—CYP3A4—Temsirolimus—kidney cancer	0.0636	0.0947	CbGbCtD
Methyltestosterone—CYP2B6—Sorafenib—kidney cancer	0.0631	0.094	CbGbCtD
Methyltestosterone—CYP2B6—Doxorubicin—kidney cancer	0.0383	0.057	CbGbCtD
Methyltestosterone—CYP3A4—Pazopanib—kidney cancer	0.0334	0.0498	CbGbCtD
Methyltestosterone—CYP3A4—Erlotinib—kidney cancer	0.0238	0.0355	CbGbCtD
Methyltestosterone—CYP3A4—Paclitaxel—kidney cancer	0.0218	0.0325	CbGbCtD
Methyltestosterone—CYP3A4—Sorafenib—kidney cancer	0.0194	0.0289	CbGbCtD
Methyltestosterone—CYP3A4—Vinblastine—kidney cancer	0.0191	0.0285	CbGbCtD
Methyltestosterone—CYP3A4—Vincristine—kidney cancer	0.0188	0.028	CbGbCtD
Methyltestosterone—CYP3A4—Sunitinib—kidney cancer	0.0157	0.0234	CbGbCtD
Methyltestosterone—Venous thromboembolism—Temsirolimus—kidney cancer	0.014	0.07	CcSEcCtD
Methyltestosterone—CYP3A4—Doxorubicin—kidney cancer	0.0118	0.0175	CbGbCtD
Methyltestosterone—SLC22A8—nephron—kidney cancer	0.0109	0.188	CbGeAlD
Methyltestosterone—Venous thromboembolism—Everolimus—kidney cancer	0.0104	0.0521	CcSEcCtD
Methyltestosterone—Oligospermia—Gemcitabine—kidney cancer	0.00979	0.0489	CcSEcCtD
Methyltestosterone—SLC22A8—urine—kidney cancer	0.00871	0.151	CbGeAlD
Methyltestosterone—Embolism venous—Temsirolimus—kidney cancer	0.00815	0.0408	CcSEcCtD
Methyltestosterone—Azoospermia—Gemcitabine—kidney cancer	0.00762	0.0381	CcSEcCtD
Methyltestosterone—Blood cholesterol increased—Everolimus—kidney cancer	0.0076	0.038	CcSEcCtD
Methyltestosterone—Embolism venous—Everolimus—kidney cancer	0.00607	0.0303	CcSEcCtD
Methyltestosterone—Menstruation irregular—Everolimus—kidney cancer	0.00553	0.0276	CcSEcCtD
Methyltestosterone—Hirsutism—Everolimus—kidney cancer	0.00527	0.0263	CcSEcCtD
Methyltestosterone—Embolism venous—Sorafenib—kidney cancer	0.00527	0.0263	CcSEcCtD
Methyltestosterone—Hirsutism—Erlotinib—kidney cancer	0.00508	0.0254	CcSEcCtD
Methyltestosterone—Oligospermia—Doxorubicin—kidney cancer	0.00434	0.0217	CcSEcCtD
Methyltestosterone—CYP3A4—urine—kidney cancer	0.00432	0.0746	CbGeAlD
Methyltestosterone—Coagulopathy—Everolimus—kidney cancer	0.00393	0.0197	CcSEcCtD
Methyltestosterone—Amenorrhoea—Everolimus—kidney cancer	0.00348	0.0174	CcSEcCtD
Methyltestosterone—Azoospermia—Doxorubicin—kidney cancer	0.00337	0.0169	CcSEcCtD
Methyltestosterone—Coagulopathy—Dactinomycin—kidney cancer	0.00311	0.0155	CcSEcCtD
Methyltestosterone—Venous thromboembolism—Doxorubicin—kidney cancer	0.00309	0.0155	CcSEcCtD
Methyltestosterone—Hirsutism—Capecitabine—kidney cancer	0.00243	0.0121	CcSEcCtD
Methyltestosterone—SHBG—gonad—kidney cancer	0.00241	0.0416	CbGeAlD
Methyltestosterone—Gynaecomastia—Sorafenib—kidney cancer	0.00238	0.0119	CcSEcCtD
Methyltestosterone—SLC22A8—nephron tubule—kidney cancer	0.00234	0.0405	CbGeAlD
Methyltestosterone—SLCO1A2—renal system—kidney cancer	0.00223	0.0386	CbGeAlD
Methyltestosterone—SLCO1A2—kidney—kidney cancer	0.00216	0.0373	CbGeAlD
Methyltestosterone—SLC22A8—renal system—kidney cancer	0.00213	0.0368	CbGeAlD
Methyltestosterone—SLC22A8—kidney—kidney cancer	0.00206	0.0356	CbGeAlD
Methyltestosterone—SLC22A8—cortex of kidney—kidney cancer	0.00201	0.0347	CbGeAlD
Methyltestosterone—Haemoglobin—Pazopanib—kidney cancer	0.00196	0.00978	CcSEcCtD
Methyltestosterone—CYP19A1—gonad—kidney cancer	0.00195	0.0338	CbGeAlD
Methyltestosterone—Haemorrhage—Pazopanib—kidney cancer	0.00195	0.00973	CcSEcCtD
Methyltestosterone—AR—renal system—kidney cancer	0.00193	0.0333	CbGeAlD
Methyltestosterone—Angiopathy—Temsirolimus—kidney cancer	0.00187	0.00937	CcSEcCtD
Methyltestosterone—AR—kidney—kidney cancer	0.00186	0.0322	CbGeAlD
Methyltestosterone—AR—cortex of kidney—kidney cancer	0.00182	0.0314	CbGeAlD
Methyltestosterone—Coagulopathy—Capecitabine—kidney cancer	0.00181	0.00905	CcSEcCtD
Methyltestosterone—Embolism venous—Doxorubicin—kidney cancer	0.0018	0.009	CcSEcCtD
Methyltestosterone—Angiopathy—Pazopanib—kidney cancer	0.00177	0.00883	CcSEcCtD
Methyltestosterone—AR—gonad—kidney cancer	0.00173	0.0299	CbGeAlD
Methyltestosterone—AR—cardiac atrium—kidney cancer	0.00173	0.0298	CbGeAlD
Methyltestosterone—Alopecia—Pazopanib—kidney cancer	0.00172	0.0086	CcSEcCtD
Methyltestosterone—Haemoglobin—Vinblastine—kidney cancer	0.00155	0.00775	CcSEcCtD
Methyltestosterone—Haemoglobin—Everolimus—kidney cancer	0.00154	0.00772	CcSEcCtD
Methyltestosterone—Haemorrhage—Vinblastine—kidney cancer	0.00154	0.00772	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Gemcitabine—kidney cancer	0.00154	0.00769	CcSEcCtD
Methyltestosterone—CYP2B6—nephron tubule—kidney cancer	0.00154	0.0266	CbGeAlD
Methyltestosterone—Haemorrhage—Everolimus—kidney cancer	0.00154	0.00769	CcSEcCtD
Methyltestosterone—Anxiety—Temsirolimus—kidney cancer	0.00153	0.00763	CcSEcCtD
Methyltestosterone—Haemoglobin—Erlotinib—kidney cancer	0.00149	0.00745	CcSEcCtD
Methyltestosterone—Haemorrhage—Erlotinib—kidney cancer	0.00148	0.00742	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Temsirolimus—kidney cancer	0.00147	0.00734	CcSEcCtD
Methyltestosterone—CYP2B6—renal system—kidney cancer	0.0014	0.0242	CbGeAlD
Methyltestosterone—Angiopathy—Everolimus—kidney cancer	0.00139	0.00697	CcSEcCtD
Methyltestosterone—Hydrocortisone—ANXA1—kidney cancer	0.00139	0.276	CrCbGaD
Methyltestosterone—Alopecia—Vinblastine—kidney cancer	0.00136	0.00682	CcSEcCtD
Methyltestosterone—Alopecia—Everolimus—kidney cancer	0.00136	0.00679	CcSEcCtD
Methyltestosterone—CYP2B6—kidney—kidney cancer	0.00135	0.0234	CbGeAlD
Methyltestosterone—Haemoglobin—Sorafenib—kidney cancer	0.00134	0.00671	CcSEcCtD
Methyltestosterone—Haemorrhage—Sorafenib—kidney cancer	0.00133	0.00667	CcSEcCtD
Methyltestosterone—Alopecia—Erlotinib—kidney cancer	0.00131	0.00655	CcSEcCtD
Methyltestosterone—Haemoglobin—Sunitinib—kidney cancer	0.00129	0.00645	CcSEcCtD
Methyltestosterone—Haemorrhage—Sunitinib—kidney cancer	0.00128	0.00642	CcSEcCtD
Methyltestosterone—CYP2B6—gonad—kidney cancer	0.00125	0.0217	CbGeAlD
Methyltestosterone—Paraesthesia—Pazopanib—kidney cancer	0.00124	0.00621	CcSEcCtD
Methyltestosterone—Angiopathy—Sorafenib—kidney cancer	0.00121	0.00605	CcSEcCtD
Methyltestosterone—Alopecia—Sorafenib—kidney cancer	0.00118	0.0059	CcSEcCtD
Methyltestosterone—Angiopathy—Sunitinib—kidney cancer	0.00116	0.00582	CcSEcCtD
Methyltestosterone—Anxiety—Everolimus—kidney cancer	0.00114	0.00568	CcSEcCtD
Methyltestosterone—Alopecia—Sunitinib—kidney cancer	0.00113	0.00567	CcSEcCtD
Methyltestosterone—Libido decreased—Capecitabine—kidney cancer	0.0011	0.00552	CcSEcCtD
Methyltestosterone—Anxiety—Erlotinib—kidney cancer	0.0011	0.00548	CcSEcCtD
Methyltestosterone—Alopecia—Dactinomycin—kidney cancer	0.00107	0.00537	CcSEcCtD
Methyltestosterone—CYP3A4—renal system—kidney cancer	0.00106	0.0183	CbGeAlD
Methyltestosterone—Haemoglobin—Gemcitabine—kidney cancer	0.00104	0.00518	CcSEcCtD
Methyltestosterone—Amenorrhoea—Doxorubicin—kidney cancer	0.00103	0.00517	CcSEcCtD
Methyltestosterone—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00103	0.00517	CcSEcCtD
Methyltestosterone—Haemorrhage—Gemcitabine—kidney cancer	0.00103	0.00515	CcSEcCtD
Methyltestosterone—CYP3A4—kidney—kidney cancer	0.00102	0.0176	CbGeAlD
Methyltestosterone—Disturbance in sexual arousal—Capecitabine—kidney cancer	0.00102	0.00508	CcSEcCtD
Methyltestosterone—Angiopathy—Vincristine—kidney cancer	0.000985	0.00493	CcSEcCtD
Methyltestosterone—Paraesthesia—Vinblastine—kidney cancer	0.000984	0.00492	CcSEcCtD
Methyltestosterone—Paraesthesia—Everolimus—kidney cancer	0.000981	0.0049	CcSEcCtD
Methyltestosterone—Alopecia—Vincristine—kidney cancer	0.00096	0.0048	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Sorafenib—kidney cancer	0.000948	0.00474	CcSEcCtD
Methyltestosterone—Angiopathy—Gemcitabine—kidney cancer	0.000935	0.00467	CcSEcCtD
Methyltestosterone—Headache—Temsirolimus—kidney cancer	0.00092	0.0046	CcSEcCtD
Methyltestosterone—Alopecia—Gemcitabine—kidney cancer	0.00091	0.00455	CcSEcCtD
Methyltestosterone—Nausea—Temsirolimus—kidney cancer	0.000872	0.00436	CcSEcCtD
Methyltestosterone—Haemoglobin—Paclitaxel—kidney cancer	0.000867	0.00433	CcSEcCtD
Methyltestosterone—Headache—Pazopanib—kidney cancer	0.000867	0.00433	CcSEcCtD
Methyltestosterone—Haemorrhage—Paclitaxel—kidney cancer	0.000863	0.00431	CcSEcCtD
Methyltestosterone—Drospirenone—BCHE—kidney cancer	0.000855	0.17	CrCbGaD
Methyltestosterone—Nausea—Pazopanib—kidney cancer	0.000822	0.00411	CcSEcCtD
Methyltestosterone—Paraesthesia—Sunitinib—kidney cancer	0.000819	0.0041	CcSEcCtD
Methyltestosterone—Angiopathy—Paclitaxel—kidney cancer	0.000783	0.00391	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Vincristine—kidney cancer	0.000772	0.00386	CcSEcCtD
Methyltestosterone—Alopecia—Paclitaxel—kidney cancer	0.000762	0.00381	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Gemcitabine—kidney cancer	0.000732	0.00366	CcSEcCtD
Methyltestosterone—Haemoglobin—Capecitabine—kidney cancer	0.000711	0.00356	CcSEcCtD
Methyltestosterone—Haemorrhage—Capecitabine—kidney cancer	0.000708	0.00354	CcSEcCtD
Methyltestosterone—Paraesthesia—Vincristine—kidney cancer	0.000693	0.00346	CcSEcCtD
Methyltestosterone—Headache—Vinblastine—kidney cancer	0.000687	0.00343	CcSEcCtD
Methyltestosterone—Headache—Everolimus—kidney cancer	0.000684	0.00342	CcSEcCtD
Methyltestosterone—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000681	0.00341	CcSEcCtD
Methyltestosterone—Headache—Erlotinib—kidney cancer	0.00066	0.0033	CcSEcCtD
Methyltestosterone—Paraesthesia—Gemcitabine—kidney cancer	0.000657	0.00329	CcSEcCtD
Methyltestosterone—Nausea—Vinblastine—kidney cancer	0.000651	0.00326	CcSEcCtD
Methyltestosterone—Nausea—Everolimus—kidney cancer	0.000649	0.00324	CcSEcCtD
Methyltestosterone—Angiopathy—Capecitabine—kidney cancer	0.000642	0.00321	CcSEcCtD
Methyltestosterone—Anxiety—Paclitaxel—kidney cancer	0.000637	0.00319	CcSEcCtD
Methyltestosterone—Nausea—Erlotinib—kidney cancer	0.000626	0.00313	CcSEcCtD
Methyltestosterone—Alopecia—Capecitabine—kidney cancer	0.000626	0.00313	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Paclitaxel—kidney cancer	0.000613	0.00306	CcSEcCtD
Methyltestosterone—Headache—Sorafenib—kidney cancer	0.000594	0.00297	CcSEcCtD
Methyltestosterone—Headache—Sunitinib—kidney cancer	0.000571	0.00286	CcSEcCtD
Methyltestosterone—Nausea—Sorafenib—kidney cancer	0.000563	0.00282	CcSEcCtD
Methyltestosterone—Paraesthesia—Paclitaxel—kidney cancer	0.00055	0.00275	CcSEcCtD
Methyltestosterone—Nausea—Sunitinib—kidney cancer	0.000542	0.00271	CcSEcCtD
Methyltestosterone—Anxiety—Capecitabine—kidney cancer	0.000523	0.00261	CcSEcCtD
Methyltestosterone—Nausea—Dactinomycin—kidney cancer	0.000513	0.00256	CcSEcCtD
Methyltestosterone—Headache—Vincristine—kidney cancer	0.000483	0.00242	CcSEcCtD
Methyltestosterone—Haemoglobin—Doxorubicin—kidney cancer	0.000459	0.00229	CcSEcCtD
Methyltestosterone—Headache—Gemcitabine—kidney cancer	0.000459	0.00229	CcSEcCtD
Methyltestosterone—Nausea—Vincristine—kidney cancer	0.000458	0.00229	CcSEcCtD
Methyltestosterone—Haemorrhage—Doxorubicin—kidney cancer	0.000456	0.00228	CcSEcCtD
Methyltestosterone—Paraesthesia—Capecitabine—kidney cancer	0.000452	0.00226	CcSEcCtD
Methyltestosterone—Nausea—Gemcitabine—kidney cancer	0.000435	0.00217	CcSEcCtD
Methyltestosterone—Angiopathy—Doxorubicin—kidney cancer	0.000414	0.00207	CcSEcCtD
Methyltestosterone—Alopecia—Doxorubicin—kidney cancer	0.000403	0.00202	CcSEcCtD
Methyltestosterone—Drospirenone—PTGS2—kidney cancer	0.000394	0.0784	CrCbGaD
Methyltestosterone—Headache—Paclitaxel—kidney cancer	0.000384	0.00192	CcSEcCtD
Methyltestosterone—Megestrol acetate—ABCB1—kidney cancer	0.000384	0.0764	CrCbGaD
Methyltestosterone—Nausea—Paclitaxel—kidney cancer	0.000364	0.00182	CcSEcCtD
Methyltestosterone—Anxiety—Doxorubicin—kidney cancer	0.000337	0.00168	CcSEcCtD
Methyltestosterone—Anaphylactic shock—Doxorubicin—kidney cancer	0.000324	0.00162	CcSEcCtD
Methyltestosterone—Headache—Capecitabine—kidney cancer	0.000315	0.00158	CcSEcCtD
Methyltestosterone—Nausea—Capecitabine—kidney cancer	0.000299	0.00149	CcSEcCtD
Methyltestosterone—Paraesthesia—Doxorubicin—kidney cancer	0.000291	0.00146	CcSEcCtD
Methyltestosterone—Progesterone—CYP1A1—kidney cancer	0.000243	0.0483	CrCbGaD
Methyltestosterone—Spironolactone—ABCB1—kidney cancer	0.000238	0.0475	CrCbGaD
Methyltestosterone—Ethinyl Estradiol—ABCB1—kidney cancer	0.00023	0.0459	CrCbGaD
Methyltestosterone—Testosterone—CYP1A1—kidney cancer	0.00023	0.0457	CrCbGaD
Methyltestosterone—Prednisone—ABCB1—kidney cancer	0.000225	0.0447	CrCbGaD
Methyltestosterone—Norethindrone—ABCB1—kidney cancer	0.000221	0.0441	CrCbGaD
Methyltestosterone—Prednisolone—ABCB1—kidney cancer	0.000207	0.0412	CrCbGaD
Methyltestosterone—Headache—Doxorubicin—kidney cancer	0.000203	0.00102	CcSEcCtD
Methyltestosterone—Nausea—Doxorubicin—kidney cancer	0.000193	0.000963	CcSEcCtD
Methyltestosterone—Hydrocortisone—ABCB1—kidney cancer	0.000158	0.0315	CrCbGaD
Methyltestosterone—Progesterone—ABCB1—kidney cancer	0.000129	0.0257	CrCbGaD
Methyltestosterone—Testosterone—ABCB1—kidney cancer	0.000122	0.0243	CrCbGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	7.1e-05	0.00108	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	7.08e-05	0.00108	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.08e-05	0.00108	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	7.07e-05	0.00108	CbGpPWpGaD
Methyltestosterone—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	7.02e-05	0.00107	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.02e-05	0.00107	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ST3GAL2—kidney cancer	6.97e-05	0.00106	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	6.95e-05	0.00106	CbGpPWpGaD
Methyltestosterone—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	6.83e-05	0.00104	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.82e-05	0.00104	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.82e-05	0.00104	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.82e-05	0.00104	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ALDH1A1—kidney cancer	6.82e-05	0.00104	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GPC3—kidney cancer	6.81e-05	0.00104	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	6.64e-05	0.00101	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CA2—kidney cancer	6.63e-05	0.00101	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	6.56e-05	0.000998	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—RPL14—kidney cancer	6.56e-05	0.000997	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PGK1—kidney cancer	6.53e-05	0.000993	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SLC5A3—kidney cancer	6.53e-05	0.000993	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KCNMA1—kidney cancer	6.52e-05	0.000992	CbGpPWpGaD
Methyltestosterone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.46e-05	0.000982	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ALAD—kidney cancer	6.46e-05	0.000981	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—LDHB—kidney cancer	6.41e-05	0.000974	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	6.4e-05	0.000973	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.32e-05	0.00096	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	6.32e-05	0.00096	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ST3GAL2—kidney cancer	6.3e-05	0.000958	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTT1—kidney cancer	6.18e-05	0.000939	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ALDH1A1—kidney cancer	6.16e-05	0.000936	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PDHB—kidney cancer	6.14e-05	0.000933	CbGpPWpGaD
Methyltestosterone—CYP2B6—Biological oxidations—POMC—kidney cancer	6.12e-05	0.00093	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	6.11e-05	0.000929	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ACY1—kidney cancer	6.08e-05	0.000924	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	6.05e-05	0.00092	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	5.98e-05	0.000909	CbGpPWpGaD
Methyltestosterone—ALB—Platelet degranulation—VEGFA—kidney cancer	5.97e-05	0.000908	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PGK1—kidney cancer	5.91e-05	0.000898	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SLC5A3—kidney cancer	5.91e-05	0.000898	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	5.89e-05	0.000895	CbGpPWpGaD
Methyltestosterone—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	5.83e-05	0.000887	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—LDHB—kidney cancer	5.79e-05	0.00088	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—PTGS1—kidney cancer	5.79e-05	0.00088	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CCBL1—kidney cancer	5.77e-05	0.000877	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	5.76e-05	0.000875	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—GRB7—kidney cancer	5.69e-05	0.000865	CbGpPWpGaD
Methyltestosterone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	5.69e-05	0.000865	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	5.65e-05	0.000859	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.61e-05	0.000853	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CA9—kidney cancer	5.56e-05	0.000844	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.44e-05	0.000827	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.43e-05	0.000825	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—EIF4EBP1—kidney cancer	5.35e-05	0.000813	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—HSPB1—kidney cancer	5.35e-05	0.000813	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—ITPR2—kidney cancer	5.29e-05	0.000804	CbGpPWpGaD
Methyltestosterone—ALB—Folate Metabolism—TP53—kidney cancer	5.26e-05	0.0008	CbGpPWpGaD
Methyltestosterone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.24e-05	0.000796	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.18e-05	0.000788	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PDHB—kidney cancer	5.17e-05	0.000785	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CA9—kidney cancer	5.02e-05	0.000763	CbGpPWpGaD
Methyltestosterone—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	5.02e-05	0.000763	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GLIPR1—kidney cancer	5e-05	0.000761	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PPAT—kidney cancer	5e-05	0.000761	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5e-05	0.00076	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—PSMD7—kidney cancer	4.97e-05	0.000756	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.91e-05	0.000746	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CCBL1—kidney cancer	4.86e-05	0.000738	CbGpPWpGaD
Methyltestosterone—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.83e-05	0.000735	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CRABP1—kidney cancer	4.72e-05	0.000718	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—FH—kidney cancer	4.65e-05	0.000707	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—APRT—kidney cancer	4.65e-05	0.000707	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—JUNB—kidney cancer	4.46e-05	0.000678	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.39e-05	0.000668	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ITPR2—kidney cancer	4.39e-05	0.000668	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GPC3—kidney cancer	4.37e-05	0.000665	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.28e-05	0.000651	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CRABP1—kidney cancer	4.27e-05	0.000649	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CA2—kidney cancer	4.26e-05	0.000647	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.22e-05	0.000642	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PPAT—kidney cancer	4.21e-05	0.00064	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GLIPR1—kidney cancer	4.21e-05	0.00064	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.16e-05	0.000632	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ALAD—kidney cancer	4.15e-05	0.00063	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.12e-05	0.000626	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.05e-05	0.000615	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ST3GAL2—kidney cancer	4.05e-05	0.000615	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ACHE—kidney cancer	4e-05	0.000609	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTT1—kidney cancer	4e-05	0.000609	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ITPR2—kidney cancer	3.97e-05	0.000603	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ALDH1A1—kidney cancer	3.96e-05	0.000601	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.93e-05	0.000598	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—FH—kidney cancer	3.92e-05	0.000595	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—APRT—kidney cancer	3.92e-05	0.000595	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IFNA1—kidney cancer	3.88e-05	0.00059	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.88e-05	0.00059	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.83e-05	0.000582	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PGK1—kidney cancer	3.79e-05	0.000576	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC5A3—kidney cancer	3.79e-05	0.000576	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SCARB1—kidney cancer	3.79e-05	0.000576	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS1—kidney cancer	3.75e-05	0.00057	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.73e-05	0.000567	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—LDHB—kidney cancer	3.72e-05	0.000565	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GPC3—kidney cancer	3.68e-05	0.00056	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PSMD7—kidney cancer	3.68e-05	0.000559	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.68e-05	0.000559	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.66e-05	0.000556	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—CDKN2B—kidney cancer	3.63e-05	0.000552	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTT1—kidney cancer	3.62e-05	0.00055	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ACHE—kidney cancer	3.62e-05	0.00055	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IFNA2—kidney cancer	3.62e-05	0.00055	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.59e-05	0.000546	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CA2—kidney cancer	3.58e-05	0.000544	CbGpPWpGaD
Methyltestosterone—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	3.57e-05	0.000543	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ALAD—kidney cancer	3.49e-05	0.000531	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—BCHE—kidney cancer	3.49e-05	0.00053	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	3.48e-05	0.000528	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.47e-05	0.000528	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SLC5A5—kidney cancer	3.45e-05	0.000524	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SCARB1—kidney cancer	3.43e-05	0.000521	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ST3GAL2—kidney cancer	3.41e-05	0.000518	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS1—kidney cancer	3.39e-05	0.000516	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ALDH1A1—kidney cancer	3.33e-05	0.000506	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—SLC2A1—kidney cancer	3.33e-05	0.000506	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PSMD7—kidney cancer	3.33e-05	0.000506	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ACY1—kidney cancer	3.28e-05	0.000499	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IGF2—kidney cancer	3.26e-05	0.000495	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.23e-05	0.000491	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CA9—kidney cancer	3.22e-05	0.00049	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC5A3—kidney cancer	3.19e-05	0.000485	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PGK1—kidney cancer	3.19e-05	0.000485	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.17e-05	0.000482	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—BCHE—kidney cancer	3.15e-05	0.000479	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—LDHB—kidney cancer	3.13e-05	0.000476	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	3.12e-05	0.000474	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SLC5A5—kidney cancer	3.11e-05	0.000473	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—SLC2A1—kidney cancer	3.01e-05	0.000457	CbGpPWpGaD
Methyltestosterone—AR—Generic Transcription Pathway—MYC—kidney cancer	2.92e-05	0.000444	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.92e-05	0.000444	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.82e-05	0.000428	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PDHB—kidney cancer	2.79e-05	0.000424	CbGpPWpGaD
Methyltestosterone—CYP3A4—Biological oxidations—POMC—kidney cancer	2.78e-05	0.000423	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTP1—kidney cancer	2.78e-05	0.000422	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CRABP1—kidney cancer	2.74e-05	0.000417	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.74e-05	0.000417	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CA9—kidney cancer	2.71e-05	0.000413	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.65e-05	0.000403	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.65e-05	0.000403	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—ABCB1—kidney cancer	2.63e-05	0.000399	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CCBL1—kidney cancer	2.62e-05	0.000399	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—GSTM1—kidney cancer	2.55e-05	0.000388	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ITPR2—kidney cancer	2.55e-05	0.000387	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.55e-05	0.000387	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTP1—kidney cancer	2.51e-05	0.000381	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	2.51e-05	0.000381	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—CYP1A1—kidney cancer	2.42e-05	0.000368	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.38e-05	0.000362	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—ABCB1—kidney cancer	2.37e-05	0.000361	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTT1—kidney cancer	2.32e-05	0.000353	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ACHE—kidney cancer	2.32e-05	0.000353	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CRABP1—kidney cancer	2.31e-05	0.000351	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—GSTM1—kidney cancer	2.31e-05	0.00035	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PPAT—kidney cancer	2.27e-05	0.000346	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.27e-05	0.000346	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SCARB1—kidney cancer	2.2e-05	0.000334	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—CYP1A1—kidney cancer	2.19e-05	0.000332	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS1—kidney cancer	2.18e-05	0.000331	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ITPR2—kidney cancer	2.15e-05	0.000326	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PSMD7—kidney cancer	2.14e-05	0.000325	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—FH—kidney cancer	2.11e-05	0.000321	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—APRT—kidney cancer	2.11e-05	0.000321	CbGpPWpGaD
Methyltestosterone—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.07e-05	0.000314	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—BCHE—kidney cancer	2.03e-05	0.000308	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC5A5—kidney cancer	2e-05	0.000304	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GPC3—kidney cancer	1.99e-05	0.000302	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.99e-05	0.000302	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.98e-05	0.000301	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTT1—kidney cancer	1.96e-05	0.000297	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ACHE—kidney cancer	1.96e-05	0.000297	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CA2—kidney cancer	1.93e-05	0.000294	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.93e-05	0.000294	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ALAD—kidney cancer	1.88e-05	0.000286	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SCARB1—kidney cancer	1.85e-05	0.000282	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.84e-05	0.00028	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS1—kidney cancer	1.83e-05	0.000279	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—POMC—kidney cancer	1.8e-05	0.000274	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PSMD7—kidney cancer	1.8e-05	0.000273	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.8e-05	0.000273	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.8e-05	0.000273	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—RAF1—kidney cancer	1.79e-05	0.000272	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PGK1—kidney cancer	1.72e-05	0.000262	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.72e-05	0.000262	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—BCHE—kidney cancer	1.7e-05	0.000259	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—LDHB—kidney cancer	1.69e-05	0.000257	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC5A5—kidney cancer	1.68e-05	0.000256	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—POMC—kidney cancer	1.63e-05	0.000248	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—SLC2A1—kidney cancer	1.63e-05	0.000247	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTP1—kidney cancer	1.61e-05	0.000245	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—IL2—kidney cancer	1.61e-05	0.000244	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.58e-05	0.00024	CbGpPWpGaD
Methyltestosterone—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.55e-05	0.000236	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—ABCB1—kidney cancer	1.53e-05	0.000232	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—GSTM1—kidney cancer	1.48e-05	0.000225	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CA9—kidney cancer	1.47e-05	0.000223	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MAPK3—kidney cancer	1.45e-05	0.00022	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTGS2—kidney cancer	1.44e-05	0.000219	CbGpPWpGaD
Methyltestosterone—AR—Gene Expression—MYC—kidney cancer	1.41e-05	0.000214	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.4e-05	0.000213	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.38e-05	0.000209	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—VEGFA—kidney cancer	1.37e-05	0.000207	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTP1—kidney cancer	1.36e-05	0.000206	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTGS2—kidney cancer	1.3e-05	0.000198	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MAPK3—kidney cancer	1.29e-05	0.000196	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—ABCB1—kidney cancer	1.28e-05	0.000195	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PTEN—kidney cancer	1.25e-05	0.000191	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—GSTM1—kidney cancer	1.25e-05	0.000189	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CRABP1—kidney cancer	1.25e-05	0.000189	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—MAPK1—kidney cancer	1.23e-05	0.000187	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—CYP1A1—kidney cancer	1.18e-05	0.00018	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—KRAS—kidney cancer	1.16e-05	0.000176	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ITPR2—kidney cancer	1.16e-05	0.000176	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PTEN—kidney cancer	1.13e-05	0.000172	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—PIK3CA—kidney cancer	1.07e-05	0.000162	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ACHE—kidney cancer	1.06e-05	0.000161	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTT1—kidney cancer	1.06e-05	0.000161	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—POMC—kidney cancer	1.05e-05	0.000159	CbGpPWpGaD
Methyltestosterone—ALB—Hemostasis—TP53—kidney cancer	1.03e-05	0.000157	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SCARB1—kidney cancer	1e-05	0.000152	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS1—kidney cancer	9.9e-06	0.00015	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.71e-06	0.000148	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PSMD7—kidney cancer	9.71e-06	0.000148	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—BCHE—kidney cancer	9.2e-06	0.00014	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC5A5—kidney cancer	9.09e-06	0.000138	CbGpPWpGaD
Methyltestosterone—SLCO1A2—Metabolism—PIK3CA—kidney cancer	8.85e-06	0.000134	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—POMC—kidney cancer	8.81e-06	0.000134	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.78e-06	0.000133	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTGS2—kidney cancer	8.35e-06	0.000127	CbGpPWpGaD
Methyltestosterone—CYP19A1—Metabolism—PIK3CA—kidney cancer	8e-06	0.000122	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTP1—kidney cancer	7.32e-06	0.000111	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PTEN—kidney cancer	7.28e-06	0.000111	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTGS2—kidney cancer	7.03e-06	0.000107	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—ABCB1—kidney cancer	6.93e-06	0.000105	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—GSTM1—kidney cancer	6.73e-06	0.000102	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.38e-06	9.69e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PTEN—kidney cancer	6.13e-06	9.31e-05	CbGpPWpGaD
Methyltestosterone—CYP2B6—Metabolism—PIK3CA—kidney cancer	5.14e-06	7.81e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—POMC—kidney cancer	4.76e-06	7.23e-05	CbGpPWpGaD
Methyltestosterone—ALB—Metabolism—PIK3CA—kidney cancer	4.32e-06	6.57e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTGS2—kidney cancer	3.79e-06	5.77e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PTEN—kidney cancer	3.31e-06	5.03e-05	CbGpPWpGaD
Methyltestosterone—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.33e-06	3.55e-05	CbGpPWpGaD
